Skip to main content
. 2023 Jan 17;15(2):82. doi: 10.3390/toxins15020082
AE Adverse effects
BoNT Botulinum toxin
CSM Corrugator supercilia muscle
DAO Depressor anguli oris
DLI Depressor labii inferioris
FM Frontalis muscle
HAS Human Serum Albumin
IM Intramuscularly
U International Unit
IV Intravenously
L Liquid
LLS Levator labii superioris
LLSAN Levator labii superioris alaeque nasi
NACL Sodium chloride
NAPs Neurotoxin-associated complexing proteins
OOc Orbicularis oculi
OOr Orbicularis oris
P Powder
PO Orally
q.s. Quantum sufficit
US Ultrasonography
Zmi Zygomaticus minor
ZMj Zygomaticus major
IP Injection points
n Number
F Female
M Male
Up Upper
L Lower
NR Not reported
HHS Vulnerability Disclosure